Coherus Oncology Inc (CHRS)

Income Before Tax

-$33.35M

Quarterly · Period ending: · USD

CHRS logo

CHRS Income Before Tax

Latest reported-$33.35M
CHRS Quarterly Pre-Tax Income (-$8.86M → -$33.35M)
High-resolution chart · PNG

CHRS income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-33,347,000
-36,935,000
-46,347,000
-44,517,000
-44,862,000
-47,398,000
-50,696,000
-10,751,000
-12,921,000
-68,036,000
-79,653,000
-40,021,000
-42,869,000
-75,729,000
-58,870,000
-86,650,000
-50,150,000
-96,084,000
-45,725,000
-38,528,000
-29,900,000
-172,947,000
10,760,000
28,116,000
60,325,000
36,505,000
41,271,000
47,890,000
23,618,000
-20,004,000
-62,596,000
-58,826,000
-43,685,000
-44,302,000
-49,069,000
-58,993,000
-55,402,000
-74,822,000
-75,944,000
83,844,000
-70,150,000
-65,538,000
-52,580,000
-71,485,000
-59,034,000
-40,839,000
-29,023,000
-7,914,000
-25,070,000
-25,170,000
-14,591,000
-21,473,000
-8,709,000
-8,862,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.